Sustainably reducing device utilization and device-related infections with DeCATHlons, device alternatives, and decision support

Infect Control Hosp Epidemiol. 2020 Nov;41(11):1344-1347. doi: 10.1017/ice.2020.295. Epub 2020 Jun 30.

Abstract

Engagement of frontline staff, along with senior leadership, in competition-style healthcare-associated infection reduction efforts, combined with electronic clinical decision support tools, appeared to reduce antibiotic regimen initiations for urinary tract infections (P = .01). Mean monthly standardized infection and device utilization ratios also decreased (P < .003 and P < .0001, respectively).

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Catheter-Related Infections* / drug therapy
  • Cross Infection* / drug therapy
  • Cross Infection* / prevention & control
  • Equipment and Supplies
  • Humans
  • Urinary Tract Infections* / drug therapy

Substances

  • Anti-Bacterial Agents